Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
Advanced search 
Year : 2020  |  Volume : 16  |  Issue : 67  |  Page : 197-200

Vanillin an active constituent from Vanilla bean induces apoptosis and inhibits proliferation in human colorectal adenocarcinoma cell line

1 Department of Gastroenterology, Tangdu Hospital, Fourth Military Medical University, Baqiao, Xi'an, Shaanxi Province, China
2 Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Baqiao, Xi'an, Shaanxi Province, China

Correspondence Address:
Yiling Zhang
Department of Oncology, Tangdu Hospital, Fourth Military Medical University, No. 569 Xinsi Road, Baqiao, Xifan 710038, Shaanxi Province
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/pm.pm_235_19

Rights and Permissions

Background: Colorectal cancers global incidence is increasing due to the rapid acquisition of Western lifestyle habits such as high caloric nutrition and sedentary status. Natural bioactive products play critical roles in anticancer drug development. Aim: The aim of the study was to investigate the antiproliferative and proapoptotic effects of vanillin (VL) an active constituent from Vanilla bean in colon cancer (human colorectal adenocarcinoma cell line [HT-29]) cells. Methodology: We demonstrated the cell growth and apoptosis in HT-29 cells. The apoptotic measures were analyzed by analyzing mitochondrial membrane potential (Δψm) level; apoptotic bodies by acridine orange/ethidium bromide and Hoechst staining. Results: Our results indicated that VL induces apoptosis as evidenced by cell viability loss, resulting in the altered Δψm in HT-29 cells. Further, the prooxidant role of VL inhibit B-cell lymphoma 2 (Bcl2) expression with the simultaneous upregulation of BCL-2 associated X, Cytochrome c, Capspase-9 and 3 protein expressions in HT-29 cells. Conclusion: Thus, in this regard, we have concluded that VL induces apoptosis in HT-29 cells through inducing oxidative damage and modulates apoptotic marker expressions. VL may therefore be used as a therapeutic agent for colon cancer treatment.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded234    
    Comments [Add]    
    Cited by others 1    

Recommend this journal